Package 75834-193-25

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 75834-193-25
Digits Only 7583419325
Product NDC 75834-193
Description

25 VIAL, SINGLE-DOSE in 1 CARTON (75834-193-25) / 1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-10-25
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "29803114-1d00-4e06-9a14-b75895c85f5a", "openfda": {"upc": ["0375834196107", "0375834193250", "0375834194257", "0375834195254"], "unii": ["V92SO9WP2I"], "rxcui": ["238212", "1731582", "1731590"], "spl_set_id": ["7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (75834-193-25)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "75834-193-25", "marketing_start_date": "20211025"}], "brand_name": "GLYCOPYRROLATE", "product_id": "75834-193_29803114-1d00-4e06-9a14-b75895c85f5a", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]"], "product_ndc": "75834-193", "generic_name": "glycopyrrolate", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA212591", "marketing_category": "ANDA", "marketing_start_date": "20211025", "listing_expiration_date": "20261231"}